» Articles » PMID: 14620395

Chemical and Microbiologic Aspects of Penems, a Distinct Class of Beta-lactams: Focus on Faropenem

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2003 Nov 19
PMID 14620395
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Many beta-lactam antimicrobials were developed between the 1960s and 1980s, with continuing development driven by the emergence of microbial resistance. Penems form a discrete class of beta-lactams that comprises structural hybrids of penicillins (penams) and cephalosporins (cephems). The chemistry and microbiology of the representative penems MEN 10700, ritipenem, CGP 31608, sulopenem, BRL 42715, and faropenem are reviewed. Particular emphasis is placed on faropenem, which is in late clinical development.

Citing Articles

In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program.

Maher J, Huband M, Blankers C, Puttagunta S, Aronin S, Castanheira M J Antimicrob Chemother. 2023; 78(6):1406-1414.

PMID: 37042351 PMC: 10232259. DOI: 10.1093/jac/dkad099.


Role of Faropenem in Treatment of Pediatric Infections: The Current State of Knowledge.

Nayak S, Pai U, Birla A Cureus. 2022; 14(4):e24453.

PMID: 35497081 PMC: 9045788. DOI: 10.7759/cureus.24453.


Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.

Zhanel G, Pozdirca M, Golden A, Lawrence C, Zelenitsky S, Berry L Drugs. 2022; 82(5):533-557.

PMID: 35294769 DOI: 10.1007/s40265-022-01688-1.


Faropenem reacts with serine and metallo-β-lactamases to give multiple products.

Lucic A, Hinchliffe P, Malla T, Tooke C, Brem J, Calvopina K Eur J Med Chem. 2021; 215:113257.

PMID: 33618159 PMC: 7614720. DOI: 10.1016/j.ejmech.2021.113257.


Assessment of urinary pharmacokinetic and pharmacodynamic profiles of faropenem against extended-spectrum -lactamase-producing with canine modelling: a pilot study.

Harada K, Shimizu T, Miyashita N, Hikasa Y Access Microbiol. 2020; 1(1):e000004.

PMID: 32974491 PMC: 7470355. DOI: 10.1099/acmi.0.000004.